SA
PFE icon

Steadfast Advisors’s Pfizer PFE Stock Holding History

Steadfast Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-95,481
Closed -$2.69M – 57
2016
Q1 		$2.69M Sell
95,481
-166,570
-64% -$4.76M 1.59% 20
2015
Q4 		$8.03M Buy
+262,051
New +$8.24M 3.72% 7

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Steadfast Advisors's PFE Position: Q2 2016 in Review

Steadfast Advisors sold out of Pfizer (PFE) in Q2 2016, closing a stake of 95,481 shares — an estimated $2.69M sold.

Steadfast Advisors first reported a position in PFE in Q4 2015 and held it in 2 quarters. The position peaked at $8.03M in Q4 2015. 1,991 funds tracked by Wall St. Rank hold PFE as of Q2 2016.

  • Steadfast Advisors reported no remaining Pfizer position as of Q2 2016 after selling out during the quarter.
  • Steadfast Advisors sold 95,481 Pfizer shares in Q2 2016, an estimated $2.69M.
  • Steadfast Advisors first reported a position in Pfizer in Q4 2015 and held it in 2 quarters.
  • Steadfast Advisors's Pfizer position peaked at $8.03M in Q4 2015.
  • 1,991 funds tracked by Wall St. Rank held Pfizer as of Q2 2016.

Based on Steadfast Advisors's 13F filing for Q2 2016, filed 15 Aug 2016.